Business Description
CanBas Co Ltd
ISIN : JP3244570002
Description
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -0.1 | |||||
| 3-Year EPS without NRI Growth Rate | -0.5 | |||||
| 3-Year FCF Growth Rate | -5 | |||||
| 3-Year Book Growth Rate | 51.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.92 | |||||
| 9-Day RSI | 62.27 | |||||
| 14-Day RSI | 52.62 | |||||
| 6-1 Month Momentum % | -47.52 | |||||
| 12-1 Month Momentum % | -73.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 26.55 | |||||
| Quick Ratio | 26.55 | |||||
| Cash Ratio | 22.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -32.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -46.09 | |||||
| ROA % | -43.52 | |||||
| ROIC % | -283.55 | |||||
| ROC (Joel Greenblatt) % | -339.84 | |||||
| ROCE % | -46.03 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.82 | |||||
| Price-to-Tangible-Book | 2.82 | |||||
| EV-to-EBIT | -6.77 | |||||
| EV-to-EBITDA | -6.77 | |||||
| EV-to-FCF | -4.63 | |||||
| Price-to-Net-Current-Asset-Value | 2.87 | |||||
| Price-to-Net-Cash | 3.34 | |||||
| Earnings Yield (Greenblatt) % | -14.77 | |||||
| FCF Yield % | -15.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CanBas Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -66.127 | ||
| Beta | -2.09 | ||
| Volatility % | 46.09 | ||
| 14-Day RSI | 52.62 | ||
| 14-Day ATR (円) | 23.757024 | ||
| 20-Day SMA (円) | 465.5 | ||
| 12-1 Month Momentum % | -73.01 | ||
| 52-Week Range (円) | 411 - 1871 | ||
| Shares Outstanding (Mil) | 18.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CanBas Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CanBas Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
CanBas Co Ltd Frequently Asked Questions
What is CanBas Co Ltd(TSE:4575)'s stock price today?
The current price of TSE:4575 is 円493.00. The 52 week high of TSE:4575 is 円1871.00 and 52 week low is 円411.00.
When is next earnings date of CanBas Co Ltd(TSE:4575)?
The next earnings date of CanBas Co Ltd(TSE:4575) is .
Does CanBas Co Ltd(TSE:4575) pay dividends? If so, how much?
CanBas Co Ltd(TSE:4575) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers